Methods for treating, preventing, and reducing the risk of the onset of Alzheimer's disease using an HMG CoA reductase inhibitor
A Standard patent application filed on 15 November 1999 credited to Wolozin, Benjamin
Details
Application number :
16241
Application type :
Standard
Application status :
SEALED
Under opposition :
No
Proceeding type :
Invention title :
Methods for treating, preventing, and reducing the risk of the onset of Alzheimer's disease using an HMG CoA reductase inhibitor
Inventor :
Wolozin, Benjamin
Agent name :
Griffith Hack
Address for service :
GPO Box 1285 MELBOURNE VIC 3001
Filing date :
15 November 1999
Associated companies :
Applicant name :
Nymox Corporation
Applicant address :
Suite 306 9900 Cavendish Boulevard Saint Laurent Quebec H4M 2V2 Canada